5-HT(4) receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice

BACKGROUND AND PURPOSE: A strategy to treat Alzheimer's disease (AD) is to increase the soluble form of amyloid precursor protein (sAPPα), a promnesic protein, in the brain. Because strong evidence supports beneficial effects of 5-hydroxytryptamine 5-HT(4) receptor agonists in memory and learni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cachard-Chastel, M, Lezoualc'h, F, Dewachter, I, Deloménie, C, Croes, S, Devijver, H, Langlois, M, Van Leuven, F, Sicsic, S, Gardier, A M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2013878/
https://ncbi.nlm.nih.gov/pubmed/17325649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707178
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados